SCHEMBL616073

SCHEMBL616073

CCOC(=O)C(=NO)c1ccc(SC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
KMT2A Q03164 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 3/20 0.48
NPSR1 Q6W5P4 3/20 0.48
MEN1 O00255 3/20 0.48
TSHR P16473 3/20 0.48
KDM4E B2RXH2 3/20 0.48
MAPK1 P28482 1/20 0.42
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
PLK1 P53350 1/20 0.41
POLB P06746 1/20 0.41
HSD17B10 Q99714 2/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HAO1 Q9UJM8 1/20 0.38
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL616072 1.00 ALDH1A1 (0.48) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2140421 0.82 ALDH1A1 (0.44) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL7622033 0.81 SMN1; SMN2 (0.50) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL6157165 0.81 KMT2A (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL7622030 0.81 SMN1; SMN2 (0.50) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL6157300 0.81 KMT2A (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL6157641 0.81 KMT2A (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL6158730 0.81 KMT2A (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL6157295 0.81 KMT2A (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL6157171 0.81 KMT2A (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12461445-B2 Low reflectivity photosensitive resin composition and light-shielding layer using same DUK SAN NEOLUX CO., LTD. (KR) 2025-11-04 US disclosed
EP-4394001-A1 REACTIVE DYE AND PHOTOSENSITIVE COMPOSITION USING SAME Duksan Neolux Co., Ltd (KR) 2024-07-03 EP disclosed
US-20240008304-A1 SEMICONDUCTOR-NANOPARTICLE-LIGAND COMPLEX, PREPARATION METHOD THEREFOR, PHOTOSENSITIVE RESIN COMPOSITION, OPTICAL FILM, ELECTROLUMINESCENT DIODE AND ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2024-01-04 US disclosed
US-20230324792-A1 PHOTOSENSITIVE COMPOSITION FOR FORMING LIGHT BLOCKING LAYER OF ORGANIC LIGHT EMITTING DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2023-10-12 US disclosed
US-20230273517-A1 LOW REFLECTIVITY PHOTOSENSITIVE RESIN COMPOSITION AND LIGHT-SHIELDING LAYER USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-08-31 US disclosed
CN-116490559-A Semiconductor nanoparticle-ligand complex, method for preparing same, photosensitive resin composition, optical film, electroluminescent diode, and electronic device 德山新勒克斯有限公司 2023-07-25 CN disclosed
WO-2023101208-A1 PHOTOSENSITIVE COMPOSITION HAVING LOW SURFACE TENSION 덕산네오룩스 주식회사 2023-06-08 WO disclosed
US-20230165028-A1 QUANTUM DOT-LIGAND COMPOSITE, PHOTOSENSITIVE RESIN COMPOSITION, OPTICAL FILM, ELECTROLUMINESCENT DIODE, AND ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2023-05-25 US disclosed
WO-2023080442-A1 REACTIVE DYE AND PHOTOSENSITIVE COMPOSITION USING SAME 덕산네오룩스 주식회사 2023-05-11 WO disclosed
US-20230100943-A1 SEMICONDUCTOR NANOPARTICLE-LIGAND COMPOSITE, MANUFACTURING METHOD OF THEREOF, PHOTOSENSITIVE RESIN COMPOSITION, OPTICAL FILM, ELECTROLUMINESCENT DIODE AND ELECTRONIC DEVICE DUKSAN NEOLUX CO., LTD (KR) 2023-03-30 US disclosed
US-7276548-B2 Colorant-containing curable composition, color filter using the composition, and method for manufacturing the same FUJIFILM CORPORATION (JP) 2007-10-02 US disclosed
US-20070099096-A1 Dye-containing curable composition, color filter and method of producing thereof FUJIFILM CORPORATION 2007-05-03 US disclosed
US-7193068-B2 Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof FUJI PHOTO FILM CO., LTD. (JP) 2007-03-20 US disclosed
US-20070049650-A1 Colorant-containing curable composition, color filter and manufacturing method thereof FUJI PHOTO FILM CO., LTD. 2007-03-01 US disclosed
US-20060293405-A1 Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof FUJI PHOTO FILM CO., LTD. 2006-12-28 US disclosed
US-20060257763-A1 Colorant-containing curable negative-type composition, color filter using the composition, and method of manufacturing the same FUJI PHOTO FILM CO., LTD. 2006-11-16 US disclosed
US-20060246364-A1 Colorant-containing curable composition, color filter and production method thereof FUJI PHOTO FILM CO., LTD. 2006-11-02 US disclosed
US-20060172149-A1 Thin film transistor and flat panel display including the same HSBC BANK CANADA (CA) 2006-08-03 US disclosed
US-20050253119-A1 Colorant-containing curable composition, color filter using the composition, and method for manufacturing the same FUJI PHOTO FILM CO., LTD. 2005-11-17 US disclosed
US-6596445-B1 Initiators for photopolymerization of radically polymerizable compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293405-A1 Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof CRKL, PDXK, RB1 ALDH1A1 932/4885MAPT 134/4885KMT2A 1062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.